Alexander Egeberg

13.1k total citations · 1 hit paper
315 papers, 8.1k citations indexed

About

Alexander Egeberg is a scholar working on Dermatology, Immunology and Immunology and Allergy. According to data from OpenAlex, Alexander Egeberg has authored 315 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 179 papers in Dermatology, 155 papers in Immunology and 68 papers in Immunology and Allergy. Recurrent topics in Alexander Egeberg's work include Psoriasis: Treatment and Pathogenesis (142 papers), Dermatology and Skin Diseases (134 papers) and Allergic Rhinitis and Sensitization (57 papers). Alexander Egeberg is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (142 papers), Dermatology and Skin Diseases (134 papers) and Allergic Rhinitis and Sensitization (57 papers). Alexander Egeberg collaborates with scholars based in Denmark, United States and United Kingdom. Alexander Egeberg's co-authors include Jacob P. Thyssen, Lone Skov, Gunnar Gislason, Peter Riis Hansen, Jashin J. Wu, Y.M.F. Andersen, Lotus Mallbris, Anne‐Sofie Halling, Farzad Alinaghi and Carsten R. Hamann and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Annals of Neurology.

In The Last Decade

Alexander Egeberg

289 papers receiving 7.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies

2018 444 citations Farzad Alinaghi, Jashin J. Wu et al. Journal of the American Academy of Dermatology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Alexander Egeberg	4.6k	3.4k	1.6k	1.6k	1.1k	315	8.1k
Phyllis I. Spuls	5.1k 1.1×	2.7k 0.8×	797 0.5×	2.7k 1.7×	1.5k 1.3×	204	8.2k
Charles Lynde	4.1k 0.9×	2.3k 0.7×	1.3k 0.8×	887 0.6×	801 0.7×	282	7.8k
E.M.G.J. de Jong	3.4k 0.7×	4.3k 1.3×	1.2k 0.8×	432 0.3×	698 0.6×	315	7.6k
Paolo Gisondi	3.3k 0.7×	5.8k 1.7×	2.5k 1.5×	453 0.3×	782 0.7×	285	8.7k
Norito Katoh	2.8k 0.6×	1.2k 0.4×	787 0.5×	1.8k 1.1×	1.1k 1.0×	263	5.1k
Mariana Castells	2.0k 0.4×	3.6k 1.1×	2.7k 1.6×	3.8k 2.4×	2.2k 2.0×	228	10.3k
Brian Kirby	2.8k 0.6×	3.6k 1.1×	1.4k 0.8×	195 0.1×	650 0.6×	203	7.7k
Matteo Megna	2.3k 0.5×	2.1k 0.6×	416 0.3×	287 0.2×	562 0.5×	249	4.1k
Gerald G. Krueger	3.6k 0.8×	7.7k 2.3×	3.1k 1.9×	296 0.2×	1.0k 0.9×	121	9.9k
Craig L. Leonardi	6.4k 1.4×	11.4k 3.4×	2.6k 1.6×	361 0.2×	2.0k 1.8×	133	14.1k

Countries citing papers authored by Alexander Egeberg

Since Specialization

Citations

This map shows the geographic impact of Alexander Egeberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Egeberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Egeberg more than expected).

Fields of papers citing papers by Alexander Egeberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Egeberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Egeberg. The network helps show where Alexander Egeberg may publish in the future.

Co-authorship network of co-authors of Alexander Egeberg

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Egeberg. A scholar is included among the top collaborators of Alexander Egeberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Egeberg. Alexander Egeberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rønnstad, Amalie Thorsti Møller, Christopher G. Bunick, Raj Chovatiya, et al.. (2025). Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis. American Journal of Clinical Dermatology. 27(1). 49–66.

Thyssen, Jacob P., et al.. (2024). Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa. JAAD International. 15. 170–178. 8 indexed citations

Hallas, Jesper, et al.. (2024). Biologics Used for Psoriasis: A Drug Utilization Study Based on Two Nationwide Danish Data Sources. Pharmacoepidemiology and Drug Safety. 33(11). e70050–e70050. 1 indexed citations

Egeberg, Alexander, et al.. (2024). Paradoxical psoriasis after dupilumab treatment of prurigo nodularis treated with adalimumab. JAAD Case Reports. 52. 146–149. 1 indexed citations

Ring, Hans Christian, Jonathan Thorsen, Brian Kirby, et al.. (2024). Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study. British Journal of Dermatology. 190(5). 769–771. 3 indexed citations

Thyssen, Jacob P., Julia‐Tatjana Maul, Peter Schmid‐Grendelmeier, et al.. (2023). The Association between Fatigue and Adult Atopic Dermatitis: A Cross-Sectional Study. Dermatitis. 34(5). 432–439. 1 indexed citations

Rasmussen, Mads Kirchheiner, Trine Bertelsen, Tomas Norman Dam, et al.. (2023). Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study. Journal of the American Academy of Dermatology. 88(6). 1378–1381. 5 indexed citations

Craiglow, Brittany G., Yang Won Lee, Sergio Vañó‐Galván, et al.. (2023). 41915 Improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata achieving scalp hair regrowth: results from two randomized controlled trials. Journal of the American Academy of Dermatology. 89(3). AB55–AB55. 1 indexed citations

Bertelsen, Trine, Alexander Egeberg, Lone Skov, et al.. (2023). Drug survival of biologic therapies for palmoplantar pustulosis: A nationwide study. Journal of the European Academy of Dermatology and Venereology. 38(2). 332–339. 1 indexed citations

10.

Egeberg, Alexander, Andreas Pinter, Ronald Vender, et al.. (2023). 42592 Baseline Characteristics and Interim Month 12 mNAPSI Results in Patients with Moderate-to- Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics in the Psoriasis Study of Health Outcomes (PSoHO). Journal of the American Academy of Dermatology. 89(3). AB127–AB127. 1 indexed citations

11.

Simpson, Eric L., Jonathan I. Silverberg, Audrey Nosbaum, et al.. (2023). 44115 Integrated Safety Analysis of Abrocitinib in 3802 Patients With Moderate-To-Severe Atopic Dermatitis With Over 5000 Patient-Years of Exposure. Journal of the American Academy of Dermatology. 89(3). AB58–AB58. 1 indexed citations

12.

Valenzuela, Fernando, Ricardo Romiti, Alexander Egeberg, et al.. (2023). 42070 Comparison of COVID-19 Vaccination Rates Among Psoriasis Patients Globally Using the Global Healthcare Study on Psoriasis (GHSP). Journal of the American Academy of Dermatology. 89(3). AB28–AB28.

13.

Shapiro, Jerry, Justin Ko, Alexander Egeberg, et al.. (2023). 41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata. Journal of the American Academy of Dermatology. 89(3). AB127–AB127. 1 indexed citations

14.

Jørgensen, Astrid‐Helene Ravn, et al.. (2023). Disease‐ and treatment‐related expectations, attitudes, and beliefs among adult patients initiating or switching biological therapies for psoriasis. SHILAP Revista de lepidopterología. 2(4). 973–982.

15.

Thyssen, Jacob P., Julia‐Tatjana Maul, Peter Schmid‐Grendelmeier, et al.. (2022). Incidence, prevalence and risk of acne in adolescent and adult patients with atopic dermatitis: a matched cohort study. Journal of the European Academy of Dermatology and Venereology. 36(6). 890–896. 16 indexed citations

16.

Vittrup, Ida, C. Droitcourt, Y.M.F. Andersen, et al.. (2021). Family burden of hospital‐managed pediatric atopic dermatitis: A nationwide registry‐based study. Pediatric Allergy and Immunology. 33(1). e13693–e13693. 6 indexed citations

17.

Gerner, Trine, Christian Vestergaard, Mette Deleuran, et al.. (2020). Healthcare utilization in Danish children with atopic dermatitis and parental topical corticosteroid phobia. Pediatric Allergy and Immunology. 32(2). 331–341. 15 indexed citations

18.

Halling, Anne‐Sofie, et al.. (2019). How does parental history of atopic disease predict the risk of atopic dermatitis in a child? A systematic review and meta-analysis. Journal of Allergy and Clinical Immunology. 145(4). 1182–1193. 51 indexed citations

19.

Egeberg, Alexander, et al.. (2017). Rosacea is associated with Helicobacter pylori: a systematic review and meta‐analysis. Journal of the European Academy of Dermatology and Venereology. 31(12). 2010–2015. 47 indexed citations

20.

Thyssen, Jacob P., Carsten R. Hamann, Allan Linneberg, et al.. (2017). Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with psychiatric hospitalization or suicide. Allergy. 73(1). 214–220. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact